tiprankstipranks
Agilent Technologies (MX:A)
NYSE:A
Mexico Market
A
Agilent
RESEARCH TOOLSreports

Agilent (A) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

A Analyst Ratings

Strong Buy
16Ratings
Strong Buy
13 Buy
3 Hold
0 Sell
Based on 16 analysts giving stock ratings to
Agilent
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

A Stock 12 Month Forecast

Average Price Target

$2,716.06
Based on 16 Wall Street analysts offering 12 month price targets for Agilent in the last 3 months. The average price target is $2,716.06 with a high forecast of $3,151.59 and a low forecast of $2,363.69. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2028":"$2,028","2309":"$2,309","2590":"$2,590","2871":"$2,871","3152":"$3,152"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3151.5915546,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.15K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2716.0591105962503,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.72K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2363.69366595,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.36K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2028,2309,2590,2871,3152],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2350,2411.6608888153846,2473.3217776307692,2534.982666446154,2596.6435552615385,2658.304444076923,2719.9653328923077,2781.6262217076924,2843.287110523077,2904.9479993384616,2966.6088881538462,3028.269776969231,3089.9306657846155,{"y":3151.5915546,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2350,2378.1583931227883,2406.316786245577,2434.4751793683654,2462.633572491154,2490.7919656139425,2518.950358736731,2547.1087518595195,2575.267144982308,2603.425538105096,2631.583931227885,2659.7423243506732,2687.900717473462,{"y":2716.0591105962503,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2350,2351.053358919231,2352.1067178384615,2353.1600767576924,2354.213435676923,2355.266794596154,2356.320153515385,2357.3735124346153,2358.4268713538463,2359.4802302730773,2360.5335891923078,2361.5869481115387,2362.6403070307692,{"y":2363.69366595,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2183.125,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2255.515,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2341.897,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2244.019,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2559.411,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2863.677,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2863.677,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2335.426,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2126.283,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2096.018,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2029.145,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2345.544,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2350,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$3,152Average Price Target$2,716Lowest Price Target$2,364
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on MX:A
Eve Burstein
Bernstein
Bernstein
$2,713.87
Buy
―
Reiterated
07/22/26
Bernstein Sticks to Its Buy Rating for Agilent (A)
Jefferies Analyst forecast on MX:A
Tycho Peterson
Jefferies
Jefferies
$2,363.69
Hold
―
Initiated
07/09/26
Analysts Are Neutral on These Healthcare Stocks: LENZ Therapeutics (LENZ), Agilent (A)
Evercore ISI Analyst forecast on MX:A
Vijay Kumar
Evercore ISI
Evercore ISI
$2,521.27→$2,591.31
Buy
―
Reiterated
07/06/26
Agilent price target raised to $148 from $144 at Evercore ISIAgilent price target raised to $148 from $144 at Evercore ISI
Barclays Analyst forecast on MX:A
Luke Sergott
Barclays
Barclays
$2,538.78→$2,626.33
Buy
―
Assigned
06/24/26
Barclays Sticks to Its Buy Rating for Agilent (A)
Piper Sandler Analyst forecast on MX:A
David Westenberg
Piper Sandler
Piper Sandler
$2,626.33
Hold
―
Initiated
06/11/26
Agilent initiated with a Neutral at Piper SandlerAgilent initiated with a Neutral at Piper Sandler
HSBC Analyst forecast on MX:A
Sidharth Sahoo
HSBC
HSBC
$3,151.59→$2,888.96
Buy
―
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Bank of America Securities Analyst forecast on MX:A
Michael Ryskin
Bank of America Securities
Bank of America Securities
$2,538.78→$2,713.87
Buy
―
Reiterated
06/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wolfe Research Analyst forecast on MX:A
Michael Polark
Wolfe Research
Wolfe Research
$2,363.69
Hold
―
Initiated
06/01/26
Agilent initiated with a Peer Perform at Wolfe ResearchAgilent initiated with a Peer Perform at Wolfe Research
Wells Fargo Analyst forecast on MX:A
Brandon Couillard
Wells Fargo
Wells Fargo
$2,888.96→$2,801.41
Buy
―
Reiterated
05/28/26
Agilent price target lowered to $160 from $165 at Wells FargoAgilent price target lowered to $160 from $165 at Wells Fargo
Stifel Nicolaus Analyst forecast on MX:A
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$2,976.5
Buy
―
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Quanterix (NASDAQ: QTRX), Bio-Techne (NASDAQ: TECH) and Agilent (NYSE: A)
Morgan Stanley Analyst forecast on MX:A
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$2,801.41
Buy
―
Reiterated
05/28/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on MX:A
Daniel Brennan
TD Cowen
TD Cowen
$2,748.89→$2,713.87
Buy
―
Reiterated
05/27/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (NYSE: PHR), Agilent (NYSE: A) and Pfizer (NYSE: PFE)
J.P. Morgan Analyst forecast on MX:A
Casey Woodring
J.P. Morgan
J.P. Morgan
$3,151.59
Buy
―
Reiterated
05/27/26
Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Apogee Therapeutics (NASDAQ: APGE) and Pfizer (NYSE: PFE)
Goldman Sachs Analyst forecast on MX:A
Evie Koslosky
Goldman Sachs
Goldman Sachs
$2,626.33→$2,713.87
Buy
―
Reiterated
05/27/26
Goldman Sachs Reaffirms Their Buy Rating on Agilent (A)
RBC Capital Analyst forecast on MX:A
Dan Leonard
RBC Capital
RBC Capital
$2,678.85
Buy
―
Reiterated
05/26/26
Agilent initiated with an Outperform at RBC CapitalAgilent initiated with an Outperform at RBC Capital
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on MX:A
Eve Burstein
Bernstein
Bernstein
$2,713.87
Buy
―
Reiterated
07/22/26
Bernstein Sticks to Its Buy Rating for Agilent (A)
Jefferies Analyst forecast on MX:A
Tycho Peterson
Jefferies
Jefferies
$2,363.69
Hold
―
Initiated
07/09/26
Analysts Are Neutral on These Healthcare Stocks: LENZ Therapeutics (LENZ), Agilent (A)
Evercore ISI Analyst forecast on MX:A
Vijay Kumar
Evercore ISI
Evercore ISI
$2,521.27→$2,591.31
Buy
―
Reiterated
07/06/26
Agilent price target raised to $148 from $144 at Evercore ISIAgilent price target raised to $148 from $144 at Evercore ISI
Barclays Analyst forecast on MX:A
Luke Sergott
Barclays
Barclays
$2,538.78→$2,626.33
Buy
―
Assigned
06/24/26
Barclays Sticks to Its Buy Rating for Agilent (A)
Piper Sandler Analyst forecast on MX:A
David Westenberg
Piper Sandler
Piper Sandler
$2,626.33
Hold
―
Initiated
06/11/26
Agilent initiated with a Neutral at Piper SandlerAgilent initiated with a Neutral at Piper Sandler
HSBC Analyst forecast on MX:A
Sidharth Sahoo
HSBC
HSBC
$3,151.59→$2,888.96
Buy
―
Reiterated
06/03/26
Agilent price target lowered to $165 from $180 at HSBCAgilent price target lowered to $165 from $180 at HSBC
Bank of America Securities Analyst forecast on MX:A
Michael Ryskin
Bank of America Securities
Bank of America Securities
$2,538.78→$2,713.87
Buy
―
Reiterated
06/02/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wolfe Research Analyst forecast on MX:A
Michael Polark
Wolfe Research
Wolfe Research
$2,363.69
Hold
―
Initiated
06/01/26
Agilent initiated with a Peer Perform at Wolfe ResearchAgilent initiated with a Peer Perform at Wolfe Research
Wells Fargo Analyst forecast on MX:A
Brandon Couillard
Wells Fargo
Wells Fargo
$2,888.96→$2,801.41
Buy
―
Reiterated
05/28/26
Agilent price target lowered to $160 from $165 at Wells FargoAgilent price target lowered to $160 from $165 at Wells Fargo
Stifel Nicolaus Analyst forecast on MX:A
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$2,976.5
Buy
―
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Quanterix (NASDAQ: QTRX), Bio-Techne (NASDAQ: TECH) and Agilent (NYSE: A)
Morgan Stanley Analyst forecast on MX:A
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$2,801.41
Buy
―
Reiterated
05/28/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on MX:A
Daniel Brennan
TD Cowen
TD Cowen
$2,748.89→$2,713.87
Buy
―
Reiterated
05/27/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (NYSE: PHR), Agilent (NYSE: A) and Pfizer (NYSE: PFE)
J.P. Morgan Analyst forecast on MX:A
Casey Woodring
J.P. Morgan
J.P. Morgan
$3,151.59
Buy
―
Reiterated
05/27/26
Analysts Offer Insights on Healthcare Companies: Agilent (NYSE: A), Apogee Therapeutics (NASDAQ: APGE) and Pfizer (NYSE: PFE)
Goldman Sachs Analyst forecast on MX:A
Evie Koslosky
Goldman Sachs
Goldman Sachs
$2,626.33→$2,713.87
Buy
―
Reiterated
05/27/26
Goldman Sachs Reaffirms Their Buy Rating on Agilent (A)
RBC Capital Analyst forecast on MX:A
Dan Leonard
RBC Capital
RBC Capital
$2,678.85
Buy
―
Reiterated
05/26/26
Agilent initiated with an Outperform at RBC CapitalAgilent initiated with an Outperform at RBC Capital
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
GKOSGlaukos
ARDXArdelyx
STOKStoke Therapeutics
MIRMMirum Pharmaceuticals
CSTLCastle Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Agilent

3 Months
Dan LeonardRBC Capital
Success Rate
18/27 ratings generated profit
67%
Average Return
+4.75%
Copying Dan Leonard's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.75% per trade.
1 Year
Brandon CouillardWells Fargo
Success Rate
33/42 ratings generated profit
79%
Average Return
+17.41%
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 78.57% of your transactions generating a profit, with an average return of +17.41% per trade.
2 Years
Puneet SoudaLeerink Partners
Success Rate
17/23 ratings generated profit
74%
Average Return
+7.80%
Copying Puneet Souda's trades and holding each position for 2 Years would result in 73.91% of your transactions generating a profit, with an average return of +7.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

A Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
2
2
2
2
2
Buy
18
16
15
15
15
Hold
1
1
0
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
19
17
19
20
In the current month, A has received 17 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. A average Analyst price target in the past 3 months is 2,716.06.
Each month's total comprises the sum of three months' worth of ratings.

A Financial Forecast

A Earnings Forecast

Next quarter’s earnings estimate for A is $26.04 with a range of $25.04 to $26.26. The previous quarter’s EPS was $26.09. A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year A has Performed in-line its overall industry.
Next quarter’s earnings estimate for A is $26.04 with a range of $25.04 to $26.26. The previous quarter’s EPS was $26.09. A beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year A has Performed in-line its overall industry.

A Sales Forecast

Next quarter’s sales forecast for A is $32.24B with a range of $32.08B to $32.41B. The previous quarter’s sales results were $32.13B. A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year A has Performed in-line its overall industry.
Next quarter’s sales forecast for A is $32.24B with a range of $32.08B to $32.41B. The previous quarter’s sales results were $32.13B. A beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year A has Performed in-line its overall industry.

A Stock Forecast FAQ

What is MX:A’s average 12-month price target, according to analysts?
Based on analyst ratings, Agilent Technologies’s 12-month average price target is 2,716.06.
    What is MX:A’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:A, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Agilent Technologies a Buy, Sell or Hold?
        Agilent Technologies has a consensus rating of Strong Buy, which is based on 13 buy ratings, 3 hold ratings and 0 sell ratings.
          What is Agilent Technologies’s share price target?
          The average share price target for Agilent Technologies is 2,716.06. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $3,151.59 ,and the lowest forecast is $2,363.69. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Agilent Technologies?
            Agilent Technologies’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
              How can I buy shares of Agilent Technologies?
              To buy shares of MX:A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.